Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.
Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.
There are obvious parallels between cannabis and psychedelics decriminalization. Are there are also differences?
For the first time since the 1970's, a small group of Canadians have been granted (federal) permission to legally use psilocybin for medicinal purposes.
The need for the medicinal benefits of psychedelic drugs is producing unlikely allies.
Big Pharma has strong incentives to embrace psychedelics. But will its predatory business model turn drug companies against these drugs?
Mydecine Innovations Group has been building momentum with a string of recent announcements.
Intelligent diversification is the key to investing in this emerging industry.
Globally, over 1 billion people are substance abusers. The U.S. addiction treatment market is already a $35 billion per year industry. Psychedelic drugs may be the (better) answer.
Seniors are now the fastest-growing demographic of cannabis consumers. This same pattern may play out as psychedelic drugs are legalized and commercialized.
The time is ripe for entry into psychedelics stocks.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now